Ceftriaxone (Xone) for Lower Respiratory Tract Infection in Adults
For hospitalized adults with bacterial LRTI, administer ceftriaxone 1 g IV once daily for at least 7 days, increasing to 2 g IV once daily for severe pneumonia requiring ICU admission or mechanical ventilation.
Dosing by Severity
Standard Community-Acquired Pneumonia (Medical Ward)
- Dose: 1 g IV once daily 1
- Duration: At least 7 days 1
- Assessment: Evaluate clinical response at day 2-3 (fever resolution, lack of radiographic progression) 1
Severe Pneumonia (ICU/Mechanical Ventilation)
- Dose: 2 g IV once daily 2
- Recent evidence demonstrates that 2 g daily reduces 30-day mortality in mechanically ventilated patients compared to 1 g daily (17.2% vs 20.4%, risk difference -3.2%) 2
- For pulmonary abscess or aspiration pneumonia, consider switching to amoxicillin-clavulanate 2 g IV every 6 hours for anaerobic coverage 1
Non-Pneumonia LRTI (Bronchitis/COPD Exacerbation)
- Dose: 1 g IV once daily 3, 4, 5, 6
- Duration: 7 days minimum 1
- Studies show 1 g daily is as effective as 2 g daily for non-severe infections 3, 4
Renal Function Adjustments
Normal renal function (CrCl >60 mL/min):
- Standard dosing: 1-2 g once daily (no adjustment needed)
Moderate impairment (CrCl 20-50 mL/min):
- 1 g every 24 hours (no dose reduction required due to dual hepatic/renal elimination)
Severe impairment (CrCl <20 mL/min):
- 1 g every 24-48 hours
- Monitor for biliary complications with prolonged therapy
Hemodialysis/CAPD:
- 1 g every 24 hours (no supplemental dose needed post-dialysis)
Key Consideration
Cystatin C-based estimates of renal function are superior to creatinine-based estimates in elderly/frail patients for predicting ceftriaxone clearance 7. In elderly patients with moderate-to-severe renal impairment, 48-hour dosing intervals may be appropriate.
β-Lactam Allergy Management
Non-Type I hypersensitivity (rash only):
- Consider alternative cephalosporins (cefotaxime 1 g IV every 8 hours) 1
- Cross-reactivity risk is low with third-generation cephalosporins
Type I hypersensitivity (anaphylaxis, angioedema):
- First-line alternative: Respiratory fluoroquinolone (levofloxacin 750 mg IV daily or moxifloxacin 400 mg IV daily) 8, 9
- Second-line: Azithromycin 500 mg IV daily PLUS either:
- Ciprofloxacin 400 mg IV every 12 hours (for gram-negative coverage), OR
- Clindamycin 600 mg IV every 8 hours (for aspiration risk) 1
Avoid: Macrolide monotherapy has poor efficacy against H. influenzae (>98% efflux-mediated resistance) and declining pneumococcal coverage 9
Common Pitfalls
Underdosing severe pneumonia: The 1 g dose may be insufficient for critically ill patients. Recent data strongly supports 2 g daily for mechanical ventilation 2, 10
Inadequate duration: Stopping at 5 days increases relapse risk. Minimum 7 days required except for azithromycin/clarithromycin regimens 1
Missing Legionella: If suspected (severe illness, hyponatremia, diarrhea), extend duration to 21 days and add azithromycin 500 mg IV daily 1
Ignoring anaerobic coverage: For aspiration risk (altered consciousness, dysphagia, poor dentition), switch to amoxicillin-clavulanate or add metronidazole 1, 8
Creatinine-only dosing in elderly: Use cystatin C when available for more accurate renal function assessment in frail patients 7
Monitoring
- Clinical response: Assess at 48-72 hours for fever resolution and lack of radiographic progression 1
- Failure to improve: Consider bronchoscopy with protected specimen brush, CT imaging, or switch to respiratory fluoroquinolone 1
- Adverse events: Monitor for C. difficile infection (slightly higher with 2 g vs 1 g dosing: 1.9% vs 1.8%) 2